Systemic anti-CD20 (rituximab) as primary treatment for symptomatic primary uveal lymphoma

PURPOSE: Uveal lymphomas are indolent, frequently choroid-involving neoplasms that are mainly CD20-positive B-cell extranodal marginal zone lymphoma. Irreversible visual loss may occur from retinal detachment and/or glaucoma among untreated symptomatic patients, or from radiation-induced changes sec...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Am J Ophthalmol Case Rep
Hlavní autoři: Tiu Teo, Honeylen Maryl, Çiftçi, Süleyman, Elner, Victor Maurice, Demirci, Hakan
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2019
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6586989/
https://ncbi.nlm.nih.gov/pubmed/31249903
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajoc.2019.100484
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky